← Home
/
Aligos Therapeutics, Inc. (ALGS)
Stock Analysis
Aligos Therapeutics, Inc. (ALGS)
ALGS
ALGS · Market data
5.35
+7.21%
Updated: 2026-06-18 13:36 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
✓
Fundamentals
Strong / Negative
✓
Price Structure
Vulnerable
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
5.97
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving ALGS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 5.97 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
📈 Net Income
-23.04M
↘ Negative
🧮 EPS (Basic)
-2.21
↘ Negative
Aligos Therapeutics, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.